# Tris Pharma, Inc. — Form D

Tris Pharma, Inc. of MONMOUTH JUNCTION, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-04. The offering totals $167.5M, of which $125.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2018-10-04
- Form: D
- Accession: 0001754826-18-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $167.5M
- Amount sold: $125.0M
- Remaining: $42.5M
- Minimum investment: $15.0M
- Investors: 3
- Date of first sale: 2018-09-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-322786

## Issuer

- Name: Tris Pharma, Inc.
- CIK: 0001754826
- Entity type: Corporation
- Jurisdiction: NEW JERSEY
- Address: 2033 ROUTE 130, MONMOUTH JUNCTION, NJ, 08852
- Phone: 732-823-4926

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Ketan Mehta | Director | Englewood, CO |
| Smita Mehta | Director | Scottsdale, AZ |
| Peter Ciano | Executive Officer | Monmouth Junction, NJ |
| Ketan Mehta | Executive Officer | Englewood, CO |

## More

- [CIK 1754826 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1754826&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001754826-18-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.